|
Since
its inception, the CTSU has offered Phase 3 Cooperative Group
cancer treatment trials for adults. The menu has expanded
to include NCI-sponsored protocols developed outside of the
Cooperative Group system. For example, international collaborations
with Groups such as the International Breast Cancer Study
Group (IBCSG) have been added to the menu at the discretion
of the Cancer Therapy Evaluation Program (CTEP). The CTSU
also works closely with regulatory staff at the National Cancer
Institute of Canada Clinical Trials Group to open CTSU menu
trials to the CTSU sites in Canada.
Protocols
involve the following disease sites:
|
|
CTSU
Phase 3 Treatment Trials
|
|
|
Breast |
|
Lung |
|
|
Gastrointestinal |
|
Lymphoma |
|
|
Genitourinary |
|
Melanoma |
 |
Gynecological |
 |
Multiple
Myeloma |
 |
Head
and Neck |
 |
Sarcoma |
|
|
Leukemia |
|
|
You
can search a listing of all active CTSU menu trials from the public
web site homepage (right side of the page under 'CTSU Protocols').
This listing contains links and documents that provide general information
about each study.
An
additional resource is the "CTSU Active Protocol List and Accrual
Report", which lists all active studies as well as accrual targets
and enrollments-to-date. This report can be found on the public
web site homepage (right side of the page under 'Reports'). It can
be also found on the members' web site under the 'Protocols' tab
and then under 'Reports'. The members' version is more robust in
that it can be run to include closed studies as well as those under
development.
Protocol
documents themselves, with all supporting materials, are located
on the members' web site under the 'Protocols' tab.
Return
to Top
|